![David Berman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Berman
Directeur Technique/Scientifique/R&D chez IMMUNOCORE HOLDINGS PLC
Fortune : - $ au 31/05/2024
Postes actifs de David Berman
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNOCORE HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/01/2019 | - |
Historique de carrière de David Berman
Anciens postes connus de David Berman
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2005 | 01/01/2015 |
Formation de David Berman
Massachusetts Institute of Technology | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Royaume-Uni | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
IMMUNOCORE HOLDINGS PLC | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 1 |
---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Bourse
- Insiders
- David Berman
- Expérience